Maximizing Weight Loss vs. Protecting the Heart: The Paradox of Modern Anti-Obesity Drugs
As global demand for anti-obesity medications surges, a fierce pharmaceutical race is underway to develop next-generation successors to blockbusters...
Search results for "GLP-1 drugs"
The Ozempic Multiplier: Why Lifestyle Habits Still Dictate Heart Health in the GLP-1 Era
It has been three months since I started my once-weekly Ozempic injection. My blood sugar is clearly under control, and I’ve lost a little weight.
Resistance in the Genes: Why Popular Obesity Drugs Don’t Work for Everyone
GLP-1 receptor agonists like Wegovy and Mounjaro have fundamentally reshaped the treatment of diabetes and obesity.
Can Wegovy and Mounjaro Reduce Cancer Risk?
Global obesity experts have proposed a large-scale, long-term follow-up study to verify whether the use of modern...
"It Wasn't Just Weight Loss That Improved My Knees"...Ozempic Study Confirms Cartilage 'Metabolic Changes'
"Please lose some weight. " This is a common phrase heard when visiting a hospital for knee pain.
The Surgeon Who Shed 36kg: Why Willpower Alone Fails Against Severe Obesity
It is hard to believe that a cardiothoracic surgeon who repairs hearts was once a patient with "super obesity.
Why ‘Elegant Dining’ Might Be the Secret to Appetite Control
If you typically rush through a sandwich at your desk or eat in a chaotic environment, you might be missing out on a...
High Efficacy and Increased Convenience: The Three Obesity Drugs Awaiting FDA Approval
Since the World Health Organization recommended the use of obesity medications for adults last December, the market is...
Oral Obesity Drug Launched in the U.S.… Where is K-Bio Pharmaceutical Now?
Denmark's Novo Nordisk's obesity drug ‘Wegovy Pill (ingredient name Semaglutide)’ has recently been launched in the U. S.
Diet Injection, Weight Loss but... What Changes Completely?
Research results indicate that GLP-1 class drugs prescribed for weight loss do not just suppress appetite but also...